Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.11 | 0.7 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |